Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. Request Sample

Craniomaxillofacial Implants Market Insights

Craniomaxillofacial is a special branch of orthopedic surgery, which focuses on all the aspects of facial and skull disorders. The craniomaxillofacial implants surgery is carried out to treat a severe injury of facial and cranial bones, where the implants are temporarily or permanently placed in the body. Trauma, accidents, and genetic defects lead to craniomaxillofacial deformities. Craniomaxillofacial implants surgery is also carried out to correct abnormalities and deformities caused by diseases such as Crouzon’s disease and Apert’s Syndrome.

In early years, the emphasis was on maintaining absolute stability of bones, without much attention on free movements. However, owing to advancements in technology and implant materials such as biocompatible titanium implants, resorbable plates, screws, and bone grafts have increased the scope for maintaining stability as well as functionality of the joints, allowing for ease of treatments related to craniomaxillofacial deformities.

The global craniomaxillofacial implants market is estimated to be valued at US$ 2,289.5 million in 2019 and is expected to witness a robust CAGR of 6.2% over the forecast period (2019-2027).

Figure 1. Global Craniomaxillofacial Implants Market Share (%), By Application, (2019)

Source: Coherent Market Insights Analysis (2019)

Technological advancements in products and adoption of new technologies are expected to favor the global craniomaxillofacial implants market growth

Increasing technological advancements and application of 3D printing in healthcare industry has Influenced manufacturers to develop new innovative products, which is expected to drive the global craniomaxillofacial implants market growth. For instance, in September 2017, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices, launched ‘TRUMATCH’ Titanium 3D-Printed Implants in the U.S., used for facial reconstruction.

Moreover, in October 2019, Zimmer Biomet Holdings Inc., a global manufacturer of musculoskeletal products, launched its ‘TrellOss-TC’ (TLIF curved), a 3D printed porous titanium interbody platform.

Rising cases of birth defects and abnormalities has resulted in increasing demand for craniomaxillofacial surgeries and expected to thrust the global craniomaxillofacial implants market growth over the forecast period

Many children are born with abnormalities such as structural defects, and the well-being of each child affected with a birth defect depends mostly on which organ or body part is involved and how much it is affected. Major birth defects such as cleft palate and anotia are treated through craniomaxillofacial surgeries. According to the Centers for Disease Control and Prevention (CDC) 2019 statistics, in the U.S., around 120,000 babies are recorded to be born with a birth defect every year. Moreover, according to the same source, 1 in every 2,800 babies are born with cleft lip or cleft palate in the U.S. and every year, 10,000 babies suffer from anotia.

Restraints

Major factors restraining the global craniomaxillofacial implants market growth are high cost of these implants and product recalls by major manufacturers such as Stryker Corporation, which had recalled Custom Cranial Implant Kits, Johnson & Johnson, which recalled jaw implants, and DePuy Synthes, which recalled Craniomaxillofacial Distraction System.

Global Craniomaxillofacial Implants Market - Regional Analysis

On the basis of region, the global craniomaxillofacial implants market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the market, owing to presence of key players such as Stryker Corporation, Zimmer Biomet, Johnson & Johnson, and others in the region. These manufacturers are engaged in developing and launching new innovative products and offer huge portfolio of products used in craniomaxillofacial surgeries. This is expected to boost the global craniomaxillofacial implants market growth.

Asia Pacific is expected to witness high growth rate in the global craniomaxillofacial implants market during the forecast period, owing to rising expenditure on healthcare by the population and increasing rate of sports-related injuries. Such sports injuries, which require craniomaxillofacial surgeries include injuries related to nasal bone, facial fracture, mandibular fracture, and others. For instance, according to NCBI, a study reported that around 2,321 people reported with nasal bone and facial fractures caused by accidents and sport injuries in Seoul, Korea during 2010-2017.

Figure 2: Global Craniomaxillofacial Implants Market Share (%), By Region, (2019 & 2027)

Source: Coherent Market Insights (2019)

Global Craniomaxillofacial Implants Market – Competitive Landscape

Some of the major players operating in the global craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic Inc., Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.